These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38593918)
1. KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA. Lu Y; Wang Y; Zhang L; Ma Z; Yu K; Shu Y; Zou X; Yang J; Liu X; Wang C; Du Y; Li Q Cancer Lett; 2024 May; 590():216869. PubMed ID: 38593918 [TBL] [Abstract][Full Text] [Related]
2. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer. Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144 [TBL] [Abstract][Full Text] [Related]
3. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma. Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710 [TBL] [Abstract][Full Text] [Related]
4. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A. Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711 [TBL] [Abstract][Full Text] [Related]
5. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma. Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435 [TBL] [Abstract][Full Text] [Related]
6. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma. Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788 [TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related]
8. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422 [TBL] [Abstract][Full Text] [Related]
9. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587 [TBL] [Abstract][Full Text] [Related]
10. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073 [TBL] [Abstract][Full Text] [Related]
11. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517 [TBL] [Abstract][Full Text] [Related]
12. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC. Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225 [TBL] [Abstract][Full Text] [Related]
13. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma. Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179 [TBL] [Abstract][Full Text] [Related]
14. Increased FGL1 Expression Predicts Poor Prognosis and Promotes EMT in Head and Neck Squamous Cell Carcinoma. Pan Z; Hu W; Huang J; Zheng Z; Lin E; Wang P; Mao L Biochem Genet; 2024 Jun; 62(3):2066-2081. PubMed ID: 37843652 [TBL] [Abstract][Full Text] [Related]
15. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma. Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905 [TBL] [Abstract][Full Text] [Related]
17. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma. Xu X; Pan X; Fan Z; Xia J; Ren X Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019 [TBL] [Abstract][Full Text] [Related]
18. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression. Liu W; Ding Z; Tao Y; Liu S; Jiang M; Yi F; Wang Z; Han Y; Zong H; Li D; Zhu Y; Xie Z; Sang S; Chen X; Miao M; Chen X; Lin W; Zhao Y; Zheng G; Zafereo M; Li G; Wu J; Zha X; Liu Y Mol Cancer; 2024 Jul; 23(1):141. PubMed ID: 38982480 [TBL] [Abstract][Full Text] [Related]
19. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma. Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213 [TBL] [Abstract][Full Text] [Related]
20. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Ma H; Chang H; Yang W; Lu Y; Hu J; Jin S Mol Cancer; 2020 Jan; 19(1):4. PubMed ID: 31907020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]